foxo4 dri senolytic 2023

foxo4 dri senolytic 2023 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Senolytics: from pharmacological inhibitors to

Name: foxo4 dri senolytic 2023 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Senolytics: from pharmacological inhibitors to
Brand: www.marsberger-treibhaus.de
SKU: 29257989046
Price: 27.46 USD
Availability: InStock
Rating: 4.7785 (14 reviews)

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice PMC FOXO4 DRI 10MG Alpha Omega Peptide Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect

SKU: 29257989046 · From www.marsberger-treibhaus.de

4.8

USD27.46 USD68.46

Pay in 4 interest-free payments of $6.87 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

AMINO-1MQ $45.00 $75.00Price range: $45.00 through $75.00This product has multiple variants

In vitro research use only Not for human or animal use metabolic MOTS-C is a mitochondria-derived peptide encoded in the 12S rRNA gene, studied in mitochondrial function and cellular metabolism research